Results 61 to 70 of about 194 (96)

Phase I—Toxicogenetics

open access: yes
Edward L. Croom, Ernest Hodgson
core   +1 more source

Kernel Multitask Regression for Toxicogenetics [PDF]

open access: yesMolecular Informatics, 2017
Abstract The development of high-throughput in vitro assays to study quantitatively the toxicity of chemical compounds on genetically characterized human-derived cell lines paves the way to predictive toxicogenetics , where one would be able to ...
Thomas Walter   +2 more
exaly   +7 more sources

Toxicogenetics: Applications and Opportunities. [PDF]

open access: yesToxicological Sciences, 2003
The response to drugs and environmental chemicals varies with genotype. Some patients react well to drugs, while others may not benefit, or may even respond adversely. Individuals also experience different reactions to environmental agents, such as allergens.
Ian Kimber, George Orphanides
exaly   +4 more sources

Toxicogenetics in Drug Development

open access: yesToxicology Letters, 2001
The major progress made in the understanding of the genetic basis of inter-individual variation in drug response, alongside the rapid advances in technology, provides major new opportunities to ensure the safe introduction of a new chemical entity into clinical practice.
Brian Kevin Park, Munir Pirmohamed
exaly   +4 more sources

Toxicogenetics of Antiretroviral Therapy: Genetic Factors That Contribute to Metabolic Complications

open access: yesAntiviral Therapy, 2007
Metabolic complications of antiretroviral therapy (ART) have emerged as a major concern for long-term, successful management of HIV infection. Variability in the response to ART between individuals has been increasingly linked to the genetic background of patients, as regards efficacy and susceptibility to adverse reactions (toxicogenetics).
Amalio Telenti, Philip E Tarr
exaly   +5 more sources

Toxicogenetics of Lopinavir/Ritonavir in Hiv-Infected European Patients

open access: yesPersonalized Medicine, 2014
We present a genetic association study in 106 European HIV-infected individuals aimed at identifying and confirming polymorphisms that have a significant influence on toxicity derived from treatment with lopinavir/ritonavir (LPV/r).Genotyping was performed by matrix-assisted laser desorption/ionization-time of flight and KASPar® (KBiosciences ...
Raquel Cruz   +2 more
exaly   +7 more sources

Home - About - Disclaimer - Privacy